A First-in-Class Approach to Treating a Rare and Chronic Liver Disease

RARECast - Podcast tekijän mukaan RARECast - Torstaisin

kokeile Podimo ilmaiseksi 90!!! päivän ajan

kokeile Podimo ilmaiseksi 90!!! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored
Podcast artwork

Kategoriat:

Talous

Sujal Shah, president and CEO of CymaBay Therapeutics, discusses the rare and chronic livers disease primary biliary cholangitis, Seladelpar, and why this first-in-class therapy has promise for addressing a condition with high unmet needs.

Visit the podcast's native language site